Our system has noticed that you are based in United States, but the current country setting is Sweden. Do you still want to change your country?

Wacker Biotech

Engage the CDMO Experts in Advanced Therapies & Biologics Manufacturing

We are passionate about working closely with our customers to develop the next generation of advanced therapeutics, for the benefit of treating, curing, and preventing diseases for patients worldwide.

Expert source for

・pDNA

・mRNA-based therapeutics

・Vaccines

・Live biotherapeutic products (LBPs)

・Proteins based on microbial systems

Better with WACKER

Our services cover:

・Strain development

・Cell banking

・Process development

・Analytical development

・GMP manufacturing

A Global CDMO Backed by a Science-Driven Powerhouse

Your needs are driving our innovation! Our five GMP-compliant facilities located in Germany, the Netherlands and United States are closely supported by corporate R&D team of our mother company Wacker Chemie AG. In close collaboration with universities and research institutions, the team of more than 180 researchers innovates new technologies and partnerships. Competitive, outstanding solutions are our trademarks.

30+ Years of Experience
1,000+ Batches On-Time and On-Budget
4 Innovative Production Platforms
200+ Client Projects
5 Commercial Releases
200+ Active Patents and Applications

Engage the Experts for:

Science-Driven Solutions

Your biologics come to life with the help of our E. coli technologies and non-IP-infringing platforms that significantly increase bioprocess efficiency, reducing the cost of goods and speeding time to market. Plus, your projects are backed by on-site experts at our manufacturing facilities and over 180 central R&D scientists in Munich.

Guidance from Concept to Commercialization

Experience seamless drug development with single source expert navigation. We've successfully managed multiple programs from feasibility studies and process development through to clinical testing and EMA/FDA-approved manufacturing for the commercial market.

A Flexible Partner who Delivers

In Wacker Biotech you have a long-term partner committed to agile, transparent communication and dedicated to your project’s success. Our track record spans 30+ years with 1,000 batches delivered on-time and on-budget, plus zero critical or major regulatory findings. All backed by a 110-year-old parent company committed to ongoing biotech capital investments.

A DIVERSE RANGE OF BIOLOGICS

pDNA

mRNA

LNP

Live Microbial Products

Proteins

Vaccines

CUSTOMIZED SERVICES WITH EXCELLENCE

Technology Transfer

Strain Development & Cell Banking

Process & Analytical Development

Process Validation

GMP Manufacturing

Services via Partnerships

OUR GLOBAL SITES

Amsterdam, The Netherlands

Home to our original mRNA Center of Excellence, the Amsterdam facility provides capabilities for developing mRNA-based processes and GMP manufacturing of customized mRNA processes while also specializing in contract manufacturing of biopharmaceutical proteins, vaccines and Live Biotherapeutic Products based on microbial systems. The site has a 250 L stirred single-use bioreactor and 1500 L stainless-steel stirred fermenter for GMP manufacturing, plus 7-20 L glass stirred single-use fermenters.

Learn more

Halle an der Saale, Germany

Our Halle facility is located on the Weinberg campus, one of Europe's leading life sciences hubs. Halle has years of experience and expertise in the production of recombinant proteins and is Wacker Biotech’s competence center for in-vitro protein refolding. It has a 1,500 L stainless-steel stirred-tank fermenter for GMP production plus several single-use fermenters at 5 L, 15 L and 150 L volumes. The site collaborates with the Halle TGZ (technology and startup center) and the many universities, companies, and institutes that innovate at the Weinberg Campus.

The Halle site is now home to a second facility, a high-end, dedicated mRNA competence center that opened in June 2024. The plant consists of four independent GMP lines (2 x 30 L and 2 x 3 L) with high production volume and state-of-the-art process design capabilities.

Learn more

Jena, Germany

Our original, flagship site, Jena is situated on the Beutenberg science campus close to Friedrich Schiller University and various scientific research institutes. It specializes in the contract manufacturing of recombinant proteins and pharmaceutical actives for clinical testing and the commercial market. It has a 350 L stainless-steel fermenter plus various single-use fermenters.

Learn more

San Diego, California, USA

Our San Diego facility specializes in pDNA production and offers extensive process development services, while also gearing up to offer mRNA and protein production. It has 6 L through 43 L flex-scale single-use bioreactors and a 650 L stainless-steel fermentation vessel, including continuous cell lysis. Corresponding primary recovery and downstream capabilities are available to suit various customer needs.

Learn more

Expert Insights

Read articles and watch videos with insights from our leaders on the latest challenges and developments in biologics process development and manufacturing.

Learn more